Skip to main content

Skin Bank Bioproducts: The Basics

  • Chapter
  • First Online:
Technology in Practical Dermatology

Abstract

Skin banks are tissue establishments dedicated to the procurement, processing, and distribution of human-derived skin bioproducts for clinical purposes. A skin bank must observe national/international guidelines and perform standardized procedures to ensure tissue traceability and biological safety in all processing stages and to avoid potential biological contamination. In order to minimize the risk of transmission of pathogenic agents, rigorous donor screening, extensive microbiological and serological tests for transmissible diseases are performed before tissue procurement; in addition, careful quality controls are conducted during tissue manipulation. Skin bank organization is complex, including multiple fully trained work teams dedicated to either the harvesting or the processing phases, employed in research laboratories or in the distribution activity and application in hospital/clinical setting. All dedicated personnel require constant training and updating. Many different types of skin bioproducts can be released from a skin bank, depending on the processing and storage method (deep-freezing/cryopreservation/glycerol-preservation/lyophilization), tissue viability, graft thickness, and the post-processing tissue preparation (meshed-expansion or not). Skin bank bioproducts have been used as a temporary dressing or, in burns, as definitive grafts in several types of loss of substance, for different clinical purposes: promotion of re-epithelization, healing time reduction, pain control, and protection of fragile subcutaneous structures (cartilage, tendons, bones, and nerves). Though a great variety of dermal matrices and skin equivalents are available, synthetic and semisynthetic, viable human skin allografts are still considered the most physiological alternative to autologous skin in burns and hard-to-heal wounds. The demand for human-derived skin bioproducts continues to be a reason for the existence of skin banks.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McCauley RL. The skin bank. Total burn care. 1st ed. Philadelphia, PA: Saunders; 1996. p. 159–63.

    Google Scholar 

  2. Mericka P. Brief history of the tissue bank, Charles University Hospital, Hradec Kralove, Czech Republic. Cell Tissue Bank. 2000;1(1):17–25.

    Article  CAS  Google Scholar 

  3. Hermans MHE. Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns. Burns. 2011;37(5):873–81.

    Article  Google Scholar 

  4. De SK, Reis ED, Kerstein MD. Wound treatment with human skin equivalent. J Am Podiatr Med Assoc. 2002;92(1):19–23.

    Article  Google Scholar 

  5. Kearney JN. Guidelines on processing and clinical use of skin allografts. Clin Dermatol. 2005;23(4):357–64.

    Article  Google Scholar 

  6. Fimiani M, Pianigiani E, Di Simplicio FC, et al. Other uses of homologous skin grafts and skin bank bioproducts. Clin Dermatol. 2005;23(4):396–402.

    Article  Google Scholar 

  7. Pianigiani E, Tognetti L, Ierardi F, et al. Il derma acellulare liofilizzato. Hi-Tech Dermo. 2016;3:17–20.

    Google Scholar 

  8. Pianigiani E, Tognetti L, Ierardi F, et al. Assessment of cryopreserved donor skin viability: the experience of the regional tissue bank of Siena. Cell Tissue Bank. 2016;17(2):241–53.

    Article  CAS  Google Scholar 

  9. Tognetti L, Pianigiani E, Ierardi F, et al. Current insights into skin banking: storage, preservation and clinical importance of skin allografts. J Biorepos Sci Appl Med. 2017;5:1–16.

    Article  Google Scholar 

  10. European Directorate for the Quality of Medicines & Health Care (EDQM). Guide to the quality and safety of tissues and cells for human application. Conseil of Europe, Strasbourg (France); 2017. 3rd ed.

    Google Scholar 

  11. Official Journal of the European Union. Directive 2004/23/EC of the European Parliament and Council on quality and safety standards for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union; 2004. Available from: http://eur-lex.europa.eu/Lex-UriServ/LexUriServ.do?uri=OJ:L:2004:102:0048:0058:en:PDF. Accessed June 5, 2017.

  12. Commission Directive 2006/17/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Available from: http://eur-lex.europa.eu/legalcontent/EN/TXT/?uri=celex%3A32006L0017. Accessed June 5, 2017.

  13. Commission Directive 2006/86/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32006L0086. Accessed June 5, 2017.

  14. European Commission [Homepage on the Internet]. EudraLex—Volume 4—Good Manufacturing Practice (GMP) guidelines; 2010 [updated December, 2010]. Available at: https://ec.europa.eu/health/documents/eudralex/vol-4_en. Accessed June 29, 2017.

  15. Center for Biologics Evaluation and Research—CBER. HCT/P’s Regulated under 21 CFR 1271.3(d)(1) and Section 361 of the PHS Act.

    Google Scholar 

  16. Wright C, Velickovic Z, Brown R, et al. Raising the standard: changes to the Australian Code of Good Manufacturing Practice (CGMP) for human blood and blood components, human tissues and human cellular therapy products. Pathology. 2014 Apr;46(3):177–83.

    Article  Google Scholar 

  17. Kagan RJ, Robb EC, Plessinger RT. Human skin banking. Clin Lab Med. 2005;25(3):587–605.

    Article  Google Scholar 

  18. Pianigiani E, Ierardi F, Cherubini F, et al. Skin bank organization. Clin Dermatol. 2005;23(4):353–6.

    Article  Google Scholar 

  19. Pianigiani E, Ierardi F, Fimiani M. Importance of good manufacturing practices in microbiological monitoring in processing human tissues for transplant. Cell Tissue Bank. 2013;14(4):601–7.

    Article  Google Scholar 

  20. Gaucher S, Elie C, Verola O, Jarraya M. Viability of cryopreserved human skin allografts: effects of transport media and cryoprotectants. Cell Tissue Bank. 2012;13(1):147–55.

    Article  CAS  Google Scholar 

  21. Linee guida per il prelievo, la processazione e la distribuzione dei tessuti a scopo di trapianto—Centro Nazionale per i Trapianti (CNT); 2015. Available from: http://www.trapianti.salute.gov.it. Accessed January 2, 2017.

  22. Vicentino M, Rodriguez G, Saldias M, Alvarez I. Guidelines to implement quality management systems in microbiology laboratories for tissue banking. Transplant Proc. 2009;41(8):3481–4.

    Article  CAS  Google Scholar 

  23. Pianigiani E, Ierardi F, Cuciti C, Brignali S, Oggioni M, Fimiani M. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors. Burns. 2010;36(3):347–51.

    Article  CAS  Google Scholar 

  24. Pianigiani E, Risulo M, Ierardi F, et al. Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy. Burns. 2006;32(3):348–51.

    Article  Google Scholar 

  25. Saegeman VS, Ectors NL, Lismont D, Verduyckt B, Verhaegen J. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts. Burns. 2008;34(2):205–11.

    Article  Google Scholar 

  26. Gaucher S, Jarraya M. Cryopreserved human skin allografts: efficacy and viability. Burns. 2014;40(3):526–7.

    Article  Google Scholar 

  27. Cleland H, Wasiak J, Dobson H, et al. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burns: a retrospective analysis. Burns. 2014;40(1):61–6.

    Article  Google Scholar 

  28. Pianigiani E, Taddeucci P, Mancini S, Miracco C. Wound healing in leg ulcers treated by combined skin allograft and autograft. J Invest Dermatol. 2001;117:544.

    Google Scholar 

  29. Towler MA, Rush EW, Richardson MK, Williams CL. Randomized, prospective, blinded-enrollment, head-to-head venous leg ulcer healing trial comparing living, bioengineered skin graft substitute (Apligraf) with living, cryopreserved, human skin allograft (TheraSkin). Clin Podiatr Med Surg. 2018;35(3):357–65.

    Article  Google Scholar 

  30. Mosti G, Mattaliano V, Picerni P, et al. Skin grafting in the treatment of hard-to-heal leg ulcers. Italian Journal of Wound Care. 2018;2(1):1–7.

    Article  Google Scholar 

  31. Khoo TL, Halim AS, Mat Saad AZ, Dorai AA. The application of glycerol-preserved skin allograft in the treatment of burn injuries: an analysis based on indications. Burns. 2010;36(8):97–904.

    Google Scholar 

  32. Leon-Villapalos J, Eldardiri M, Dziewulski P. The use of human deceased donor skin allografts in burn care. Cell Tissue Bank. 2010;11(1):99–104.

    Article  Google Scholar 

  33. Kua EH, Goh CQ, Ting Y, Chua A, Song C. Comparing the use of glycerol preserved and cryopreserved allogenic skin for the treatment of severe burns: differences in clinical outcomes and in vitro tissue viability. Cell Tissue Bank. 2012;13(2):269–79.

    Article  CAS  Google Scholar 

  34. Ferrando PM, Balmativola B, Cambieri I, et al. Glycerolized reticular dermis as a new human acellular dermal matrix: an exploratory study. PLOS One. 2016;11(2):e0149124.

    Article  Google Scholar 

  35. Rooney P, Eagle M, Hogg P, et al. Sterilisation of skin allograft with gamma irradiation. Burns. 2008;34(5):664–73.

    Article  CAS  Google Scholar 

  36. Jansen LA, De Caigny P, Guay NA, et al. The evidence base for the acellular dermal matrix AlloDerm: a systematic review. Ann Plast Surg. 2013;70(5):587–94.

    Article  CAS  Google Scholar 

  37. Lattari V, Jones LM, Varcelotti JR, et al. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil. 1997;18:147–55.

    Article  CAS  Google Scholar 

  38. Moerman E, Middelkoop E, Mackie D, et al. The temporary use of allograft for complicated wounds in plastic surgery. Burns. 2002;28:S13–5.

    Article  Google Scholar 

  39. Cuono CB, Langdon R, Birchall N, et al. Composite autologous allogeneic skin replacement: development and clinical application. Plast Reconstr Surg. 1987;80(4):626–37.

    Article  CAS  Google Scholar 

  40. Pianigiani E, Ierardi F, Mazzanti B, et al. Human de-epidermized dermis as a stem cell carrier. Transplant Proc. 2010;42:2244–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tognetti, L. et al. (2020). Skin Bank Bioproducts: The Basics. In: Fimiani, M., Rubegni, P., Cinotti, E. (eds) Technology in Practical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-45351-0_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-45351-0_41

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-45350-3

  • Online ISBN: 978-3-030-45351-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics